デフォルト表紙
市場調査レポート
商品コード
1301038

細胞バンキングアウトソーシング市場規模、シェア、動向分析レポート:タイプ別(マスターセルバンキング、ワーキングセルバンキング、ウイルスセルバンキング)、細胞タイプ別、フェーズ別、地域別、セグメント予測、2023年~2030年

Cell Banking Outsourcing Market Size, Share & Trends Analysis Report By Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking), By Cell Type, By Phase, By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 180 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.46円
細胞バンキングアウトソーシング市場規模、シェア、動向分析レポート:タイプ別(マスターセルバンキング、ワーキングセルバンキング、ウイルスセルバンキング)、細胞タイプ別、フェーズ別、地域別、セグメント予測、2023年~2030年
出版日: 2023年06月14日
発行: Grand View Research
ページ情報: 英文 180 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

細胞バンキングアウトソーシング市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の細胞バンキングアウトソーシング市場規模は2030年までに355億9,000万米ドルに達し、CAGRは16.34%を記録すると予測されています。

細胞株の収集、検査、保存のための新技術のイントロダクションは、予測期間中に細胞バンキング市場を押し上げると予想されます。臍帯血の処理と保存における自動化は、市場の成長に影響を与えると予想される主要技術です。

CellTrials.orgの調べによると、2020年第1四半期における先進細胞治療の新規臨床試験の登録件数は世界全体で約30%増加しました。この増加のほとんどは、COVID-19を治療するための細胞治療への取り組みに関連するものであり、COVID-19を対象とした臨床試験の半数以上が臍帯MSCを採用しています。したがって、パンデミックは、MSCs製品の製造に携わる企業にとって新たな市場を創出しました。

Pharma Intelligence UK Limitedが発表した報告書によると、2022年には21種類のがん治療薬が発売される見込みです。さらに、これらの医薬品はさまざまな代謝異常の治療に使用されるため、予測期間中に新規バイオシミラー医薬品の市場参入が増加することになります。例えば、2022年に医薬品評価研究センター(CDER)は15の新薬と生物学的製剤を承認しました。細胞株は、これらのバイオ医薬品の生産と試験にとって非常に貴重な資産です。それゆえ、バイオシミラーや生物学的製剤の研究開発活動の増加は、良質な細胞株への需要を高め、バンキング・サービスの需要に拍車をかけると予想されます。

モノクローナル抗体産業は、自己免疫疾患、がん、炎症性疾患など幅広い疾患の治療など、その利点から急速なペースで成長しています。高い効率性、高い特異性、比較的少ない副作用を示すモノクローナル抗体によってもたらされる利点により、これらの疾患の治療に対するモノクローナル抗体の需要は予測期間中に増加すると予想されます。

モノクローナル抗体を用いた実行可能な治療法の増加や、臨床開発に関連する様々な新しい手法のイントロダクションは、モノクローナル抗体の成長を促進すると予想されます。最も優れた特性を持つクローンが選ばれ、バンクに保管されることで、モノクローナル抗体の生産は10年間繰り返されます。従って、モノクローナル抗体の増加は、予測期間を通じてバンクの需要を促進すると予想されます。

ヒト胚研究は、人間の生命の価値を尊重し、苦しみを防ぐという道徳的な義務を課しています。胚性幹細胞の採取は、ヒト胚の破壊につながるため、人命尊重の義務に違反します。加えて、研究に使用される製品や材料に対する知的財産権(IPR)の付与や、そのようなサービスの商業化は、細胞開発における大きな制約です。細胞株や組織をバイオリポジトリに保管する前に、倫理的な承認を得る必要があります。この技術により、DNAだけで患者を特定できるようになるため、違法な目的での組織の悪用や、保険金請求のための病気の代理特定につながる可能性があります。

細胞バンキングアウトソーシング市場レポートハイライト

  • 2022年の市場シェアはマスターセルバンクが最も高かったです。さらに、マスターセルバンクは実用細胞バンクの準備に有用であるため、遺伝子治療の様々な研究開発において応用が可能であり、その結果、同分野の成長がもたらされます。

内容ができる

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
    • セグメントの定義
  • 情報調達
  • 情報またはデータ分析
  • 市場範囲とセグメントの定義
  • 市場モデル
    • 企業市場シェア別の市場調査
    • 地域分析

第2章 エグゼクティブサマリー

  • 市場スナップショット
  • セグメントのスナップショット
  • 競合情勢のスナップショット

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助的な市場見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19の影響分析

第4章 タイプビジネス分析

  • 細胞バンキングアウトソーシング市場:タイプ変動分析
  • マスターセルバンキング
    • マスターセルバンキング市場、2018年~2030年(100万米ドル)
  • ワーキングセルバンキング
    • ワーキングセルバンキング市場、2018年~2030年(100万米ドル)
  • ウイルスセルバンキング
    • ウイルスセルバンキング市場、2018年~2030年(100万米ドル)

第5章 細胞型ビジネス分析

  • 細胞バンキングアウトソーシング市場:細胞タイプの変動分析
  • 幹細胞
    • 幹細胞市場、2018~2030年(100万米ドル)
    • 臍帯細胞バンキング
    • ES細胞バンク
    • 成人幹細胞バンク
    • 歯科用幹細胞バンク
    • IPS幹細胞バンキング
  • 非幹細胞
    • 非幹細胞市場、2018年~2030年(100万米ドル)

第6章 フェーズのビジネス分析

  • 細胞バンキングアウトソーシング市場:フェーズ変動分析
  • 銀行保管庫
    • 銀行保管市場、2018~2030年(100万米ドル)
    • マスターセルバンクの準備
    • ワーキングセルバンクの準備
    • セルの保存安定性試験
  • 銀行の特性評価とテスト
    • 銀行の特性評価およびテスト市場、2018~2030年(100万米ドル)
    • 安全性試験
    • 遺伝子発現検査
    • 核学検査
    • 遺伝子配列検査
  • 銀行の準備
    • 銀行準備市場、2018-2030(100万米ドル)
    • マスターセルバンクの準備
    • ワーキングセルバンクの準備

第7章 地域ビジネス分析

  • 地域別細胞バンキングアウトソーシング市場シェア、2022年および2030年
  • 北米
    • SWOT分析
    • 北米の細胞バンキングアウトソーシング市場、2018年~2030年(100万米ドル)
    • 米国
    • カナダ
  • 欧州
    • SWOT分析
    • 欧州の細胞バンキングアウトソーシング市場、2018~2030年(100万米ドル)
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • SWOT分析
    • アジア太平洋の細胞バンキングアウトソーシング市場、2018年~2030年(100万米ドル)
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • SWOT分析
    • ラテンアメリカの細胞バンキングアウトソーシング市場、2018年~2030年(100万米ドル)
    • ブラジル
    • メキシコ
    • アルゼンチン
  • MEA
    • SWOT分析
    • MEA細胞バンキングアウトソーシング市場、2018年~2030年(100万米ドル)
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 会社分類
  • 戦略マッピング
  • 企業の市場シェア分析、2022年
  • 企業プロファイル・一覧表
    • Bio Outsource(Sartorious)
    • BSL Bioservice
    • Cryo-Cell International, Inc.
    • Charles River Laboratories
    • LifeCell
    • GBI
    • Lonza
    • SGS Societe Generale de Surveillance SA
    • Perfectus Biomed Limited
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 3 Global Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 4 Global Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 5 Global Cell banking outsourcing market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America Cell banking outsourcing market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 9 North America Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 10 U.S. Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Cell banking outsourcing Market, by phase, 2018 - 2030 (USD Million)
  • Table 13 Canada Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 15 Canada Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 16 Europe Cell banking outsourcing market, by country, 2018 - 2030 (USD Million)
  • Table 17 Europe Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 18 Europe Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 19 Europe Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 20 UK Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 21 UK Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 22 UK Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 23 Germany Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 24 Germany Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 25 Germany Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 26 France Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 27 France Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 28 France Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 29 Italy Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 30 Italy Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 31 Italy Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 32 Spain Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 33 Spain Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 34 Spain Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 35 Denmark Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 36 Denmark Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 37 Denmark Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 38 Sweden Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 39 Sweden Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 40 Sweden Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 41 Norway Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 42 Norway Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 43 Norway Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Cell banking outsourcing market, by country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 48 Japan Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 49 Japan Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 50 Japan Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 51 China Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 52 China Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 53 China Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 54 India Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 55 India Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 56 India Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 57 Australia Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 58 Australia Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 59 Australia Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 60 Thailand Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 61 Thailand Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 62 Thailand Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 63 South Korea Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 64 South Korea Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 65 South Korea Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 66 Latin America Cell banking outsourcing market, by country, 2018 - 2030 (USD Million)
  • Table 67 Latin America Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 68 Latin America Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 69 Latin America Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 70 Brazil Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 71 Brazil Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 72 Brazil Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 73 Mexico Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 74 Mexico Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 75 Mexico Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 76 Argentina Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 77 Argentina Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Cell banking outsourcing market, by country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 83 South Africa Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 84 South Africa Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 89 UAE Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 90 UAE Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 91 UAE Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Cell banking outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Cell banking outsourcing market, by cell type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Cell banking outsourcing market, by phase, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 single-cell omics market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global Cell banking outsourcing market: type movement analysis
  • Fig. 15 Global Cell banking outsourcing market, for master cell banking, 2018 - 2030 (USD Million)
  • Fig. 16 Global Cell banking outsourcing market, for working cell banking, 2018 - 2030 (USD Million)
  • Fig. 17 Global Cell banking outsourcing market, for viral cell banking, 2018 - 2030 (USD Million)
  • Fig. 18 Global Cell banking outsourcing market: Cell type movement analysis
  • Fig. 19 Global Cell banking outsourcing market, for stem cells, 2018 - 2030 (USD Million)
  • Fig. 20 Global cord cell banking market, 2018 - 2030 (USD Million)
  • Fig. 21 Global embryonic stem cell market, 2018 - 2030 (USD Million)
  • Fig. 22 Global adult stem cell banking market, 2018 - 2030 (USD Million)
  • Fig. 23 Global dental stem cell banking market, 2018 - 2030 (USD Million)
  • Fig. 24 Global IPS stem cell banking market, 2018 - 2030 (USD Million)
  • Fig. 25 Global Cell banking outsourcing market: Phase movement analysis
  • Fig. 26 Global bank storage market, 2018 - 2030 (USD Million)
  • Fig. 27 Global master cell bank prep market, 2018 - 2030 (USD Million)
  • Fig. 28 Global working cell bank prep market, 2018 - 2030 (USD Million)
  • Fig. 29 Global cell storage stability testing market, 2018 - 2030 (USD Million)
  • Fig. 30 Global bank characterization & testing market, 2018 - 2030 (USD Million)
  • Fig. 31 Global safety testing market, 2018 - 2030 (USD Million)
  • Fig. 32 Global viral cell banks market, 2018 - 2030 (USD Million)
  • Fig. 33 Global gene expression testing market, 2018 - 2030 (USD Million)
  • Fig. 34 Global karyology testing market, 2018 - 2030 (USD Million)
  • Fig. 35 Global gene sequencing testing market, 2018 - 2030 (USD Million)
  • Fig. 36 Global bank preparation market, 2018 - 2030 (USD Million)
  • Fig. 37 Global master cell bank prep market, 2018 - 2030 (USD Million)
  • Fig. 38 Global working cell bank prep market, 2018 - 2030 (USD Million)
  • Fig. 39 Regional marketplace: Key takeaways
  • Fig. 40 Regional outlook, 2022 & 2030
  • Fig. 41 Global Cell banking outsourcing market: Region movement analysis
  • Fig. 42 North America Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 43 U.S. Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 44 Canada Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 45 Europe Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 46 Germany Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 47 UK Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 48 France Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 49 Italy Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 50 Spain Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 53 Norway Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 55 Japan Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 56 China Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 57 India Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 58 Australia Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 59 South Korea Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 60 Thailand Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 61 Latin America Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 62 Brazil Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 63 Mexico Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 64 Argentina Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 65 Middle East and Africa Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 66 South Africa Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 67 Saudi Arabia Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 68 UAE Cell banking outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 69 Kuwait Cell banking outsourcing market, 2018 - 2030 (USD Million)
目次
Product Code: 978-1-68038-581-6

Cell Banking Outsourcing Market Growth & Trends

The global cell banking outsourcing market size is expected to reach USD 35.59 billion by 2030, registering a CAGR of 16.34%, according to a new report by Grand View Research, Inc. Introduction of novel technologies for the collection, testing, and storage of cell lines are expected to boost the cell banking market during the forecast period. Automation in cord blood processing and storage are the key technologies that are expected to affect the growth of the market.

CellTrials.org found that global enrolments of new trials in advanced cell therapy were up almost 30% in the first quarter of 2020. Most of the rise can be associated with cell therapy efforts for treating COVID-19, and over half of those trials for COVID-19 employ umbilical cord MSCs. Hence, the pandemic has created a new market for those companies which are engaged in the manufacturing of MSCs products.

According to a report published by Pharma Intelligence UK Limited, 21 oncological drugs are expected to be launched in 2022. Moreover, these drugs will be used for the treatment of different metabolic disorders which would result in the increased entry of novel biosimilar drugs into the market during the forecast period. For instance, in 2022, Center for Drug Evaluation and Research (CDER), approved 15 new drugs and biological products. Cell lines are highly valuable assets for the production and testing of these biopharmaceuticals. Hence, the increasing number of R&D activities for biosimilar and biologic products is expected to increase demand for the good-quality cell lines, thereby, fueling the demand for banking services.

Monoclonal antibody industry is growing at a rapid pace, owing to the advantages associated with it such as treatment for a wide array of diseases including autoimmune diseases, cancer, and inflammatory diseases. The demand for monoclonal antibodies for the treatment of these diseases is expected to increase during the forecast period, due to the benefits offered by them, which exhibit high efficiency, high specificity, and comparatively lesser side effects.

The increasing number of monoclonal antibody-based viable therapies, as well as the introduction of various new modalities related to their clinical development, are expected to drive the growth of the monoclonal antibodies. A clone with the best properties is chosen and stored in a bank, allowing for the production of monoclonal antibodies to be repeated for a decade. Therefore, the increasing growth of monoclonal antibodies is expected to propel the demand for banking throughout the forecast period.

Human embryonic research poses a moral duty such as respecting the value of human life and preventing suffering. The harvesting of embryonic stem cells violates the duty of respect value for human life as it is a consequence of the destruction of human embryos. In addition, granting of intellectual property rights (IPR) to the product or material used in research and commercialization of such services are the major restraints in cell development. Ethical approval should be obtained before the storage of cell lines and tissues in biorepositories as the technology allows patients identification just from DNA; which may lead to the misuse of tissue for an illegal purpose or for proxy identification of diseases to claim insurance.

Cell Banking Outsourcing Market Report Highlights

  • Master cell banking accounted for the largest market share in 2022, owing to rise in these facilities across the globe. Moreover, master cell banks are useful for the preparation of working cell banks and thus find applicability in various research and development perspectives for gene therapy thereby resulting to segment growth

able of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Definitions
  • 1.2. Information Procurement
  • 1.3. Information Or Data Analysis
  • 1.4. Market Scope & Segment Definition
  • 1.5. Market Model
    • 1.5.1. Market Study, By Company Market Share
    • 1.5.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technological Advancement Involving Cell Banking
      • 3.2.1.2. Patent Expiration Of Blockbuster Biologics
      • 3.2.1.3. Rising Demand For Monoclonal Antibodies
      • 3.2.1.4. Growing R&D Investments In Biotechnology Sector
      • 3.2.1.5. Increasing Prevalence Of Cancer
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Ethical Concern Related To Stem Cell Research
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Cell Banking Outsourcing Market: Type Movement Analysis
  • 4.2. Master Cell Banking
    • 4.2.1. Master Cell Banking Market, 2018 - 2030 (USD Million)
  • 4.3. Working Cell Banking
    • 4.3.1. Working Cell Banking Market, 2018 - 2030 (USD Million)
  • 4.4. Viral Cell Banking
    • 4.4.1. Viral Cell Banking Market, 2018 - 2030 (USD Million)

Chapter 5. Cell-Type Business Analysis

  • 5.1. Cell Banking Outsourcing Market: Cell-Type Movement Analysis
  • 5.2. Stem Cell
    • 5.2.1. Stem Cell Market, 2018 - 2030 (USD Million)
    • 5.2.2. Cord Cell Banking
      • 5.2.2.1. Cord Cell Banking Market, 2018 - 2030 (USD Million)
    • 5.2.3. Embryonic Stem Cell Banking
      • 5.2.3.1. Embryonic Stem Cell Banking Market, 2018 - 2030 (USD Million)
    • 5.2.4. Adult Stem Cell Banking
      • 5.2.4.1. Adult Stem Cell Banking Market, 2018 - 2030 (USD Million)
    • 5.2.5. Dental Stem Cell Banking
      • 5.2.5.1. Dental Stem Cell Banking Market, 2018 - 2030 (USD Million)
    • 5.2.6. IPS Stem Cell Banking
      • 5.2.6.1. IPS Stem Cell Banking Market, 2018 - 2030 (USD Million)
  • 5.3. Non-Stem Cell
    • 5.3.1. Non-Stem Cell Market, 2018 - 2030 (USD Million)

Chapter 6. Phase Business Analysis

  • 6.1. Cell Banking Outsourcing Market: Phase Movement Analysis
  • 6.2. Bank Storage
    • 6.2.1. Bank Storage Market, 2018 - 2030 (USD Million)
    • 6.2.2. Master Cell Bank Preparation
      • 6.2.2.1. Master Cell Bank Preparation Market, 2018 - 2030 (USD Million)
    • 6.2.3. Working Cell Bank Preparation
      • 6.2.3.1. Working Cell Bank Preparation Market, 2018 - 2030 (USD Million)
    • 6.2.4. Cell Storage Stability Testing
      • 6.2.4.1. Cell Storage Stability Testing Market, 2018 - 2030 (USD Million)
  • 6.3. Bank Characterization & Testing
    • 6.3.1. Bank Characterization & Testing Market, 2018 - 2030 (USD Million)
    • 6.3.2. Safety Testing
      • 6.3.2.1. Safety Testing Market, 2018 - 2030 (USD Million)
      • 6.3.2.1.1. Viral Cell Banks
      • 6.3.2.1.1.1. Viral Cell Banks Market, 2018 - 2030 (USD Million)
      • 6.3.2.1.2. Microbial Cell Banks
      • 6.3.2.1.2.1. Microbial Cell Banks Market, 2018 - 2030 (USD Million)
    • 6.3.3. Gene Expression Testing
      • 6.3.3.1. Gene Expression Testing Market, 2018 - 2030 (USD Million)
    • 6.3.4. Karyology Testing
      • 6.3.4.1. Karyology Testing Market, 2018 - 2030 (USD Million)
    • 6.3.5. Gene Sequencing Testing
      • 6.3.5.1. Gene Sequencing Testing Market, 2018 - 2030 (USD Million)
  • 6.4. Bank Preparation
    • 6.4.1. Bank Preparation Market, 2018 - 2030 (USD Million)
    • 6.4.2. Master Cell Bank Preparation
      • 6.4.2.1. Master Cell Bank Preparation Market, 2018 - 2030 (USD Million)
    • 6.4.3. Working Cell Bank Preparation
      • 6.4.3.1. Working Cell Bank Preparation Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Cell Banking Outsourcing Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. U.S. Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Competitive Scenario
      • 7.2.4.3. Canada Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. UK Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.3.4. Germany
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Germany Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. France Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Italy Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Spain Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.3.8. Denmark
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Denmark Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Sweden Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.3.10. Norway
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Competitive Scenario
      • 7.3.10.3. Norway Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Japan Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. China Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. India Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Australia Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Thailand Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.4.8. South Korea
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. South Korea Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Brazil Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Mexico Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Argentina Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. SWOT Analysis
    • 7.6.2. MEA Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. South Africa Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Saudi Arabia Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.6.5. UAE
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. UAE Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)
    • 7.6.6. Kuwait
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Kuwait Cell Banking Outsourcing Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. Bio Outsource (Sartorious)
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. BSL Bioservice
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Cryo-Cell International, Inc.
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Charles River Laboratories
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. LifeCell
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. GBI
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Lonza
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. SGS Societe Generale de Surveillance SA
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Perfectus Biomed Limited
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives